Precision Nuclear Medicine hub

Radiopharmaceuticals and Targeted Therapies

Radiopharmaceutical science is transforming molecular imaging and cancer treatment through targeted diagnostic and therapeutic compounds. This hub covers tracer development, radiolabelling methods, radiopharmacy practice, radiotheranostics, and therapeutic radionuclides. It highlights production standards, quality control, clinical translation, and emerging research supporting personalised medicine. The content serves scientists, clinicians, pharmacists, and industry professionals working in nuclear medicine and targeted therapy programmes.

Medical radiopharmaceuticals assist diagnosis and treatment using SPECT, PET, gamma

Radiopharmaceuticals

Medical radiopharmaceuticals use SPECT, PET, and gamma camera imaging to enable accurate diagnosis and targeted therapy. Their clinical application requires rigorous safety standards, robust quality control, and regulatory approval to ensure reliable, effective, and patient-centred care.

FDA-Radiopharm ensures radiopharmaceuticals meet strict safety and efficacy standards

Radiopharmacy

Radiopharmacy focuses on the development, preparation, and dispensing of radiopharmaceuticals for both diagnostic and therapeutic use. It upholds strict quality, safety, and regulatory standards, enabling nuclear medicine services to deliver accurate imaging and effective targeted treatments for patients.

Radiotheranostics combines diagnosis and therapy targeting with radiolabelled compounds

Radiotheranostics

Radiotheranostics integrates diagnostic imaging and targeted therapy through the use of radiopharmaceuticals to detect and treat cancer. This approach improves precision, treatment effectiveness, and personalised care, representing a major advance in modern nuclear medicine.

Radiolabelling enables precise tracking of compounds in complex biological systems

Radiolabelling

Radiolabelling involves incorporating radioactive isotopes into molecules to trace their movement, transformation, and biological fate within complex systems. It supports high-sensitivity research in drug development, environmental science, and biochemical pathway analysis with strong precision and reliability.

Medical radiotherapeutics use radionuclides to selectively target cancer cells

Radiotherapeutics

Medical radiotherapeutics use targeted radionuclides such as actinium-225 to treat cancer with high precision. This approach minimises damage to healthy tissue while supporting personalised therapy that improves treatment effectiveness and patient care outcomes.